• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Emeline Aviki: Telehealth Allows Patients a Quick Return to Daily Life

Video

There is a major role for telehealth in oncology care, not only for its convenience but also for giving clinicians the ability to scale nononcologic visits, explained Emeline Aviki, MD, MBA, FACOG, assistant attending gynecologic cancer surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and lead of the MSKCC Affordability Working Group.

In an interview at our September Institute for Value-Based Medicine® event in New York City, Emeline Aviki, MD, MBA, FACOG, assistant attending gynecologic cancer surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and lead of the MSKCC Affordability Working Group, discussed how benefits of telehealth in oncologic care extend to other specialty care for patients.

Transcript

What role does telehealth play in oncology care?

Telehealth has a major role in cancer care. I think the COVID-19 pandemic showed us how valuable telehealth can be, not only for patient convenience, but also to make sure that patients are compliant with follow-up. Telehealth can offer a lot of convenience for patients.

If you have a follow-up visit with a patient where they don't need a physical exam and they can get their labs at a time that's convenient for them, that's the perfect opportunity to not force them to have to pay for parking [and] take a day off work. Just take a break during work, do your visit with your oncologist, and get back to life.

In addition to offering patients convenient oncology visits, it also offers the ability to scale nononcologic visits that are very helpful for patients; for example, psychiatric care, supportive care for pain management. It would allow you to get those services that are really in shortage to patients no matter where they are.

Related Videos
Rashon Lane, PhD, MA
Dr Julie Patterson, National Pharmaceutical Council
Diana Isaacs, PharmD
Beau Raymond, MD
Binod Dhakal, MD, Medical College of Wisconsin, lead CARTITUDE-4 investigator
Dr Sophia Humphreys
Robert Zimmerman, MD
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Ryan Stice, PharmD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.